

Table of Contents
Articles
Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States
Carl L. Roland, PharmD, Ashish V. Joshi, PhD, Jack Mardekian, PhD, Steven C. Walden, PharmD, MBA, James Harnett, PharmD, MS
|
161—175
|
Lisa R. Witkin, MD, Dina Diskina, BS, Shawn Fernandes, BS, John T. Farrar, MD, PhD, Michael A. Ashburn, MD, MPH
|
177—187
|
Myoung Kim, PhD, Wing Chow, PharmD, MPH, Carmela Benson, MS
|
189—196
|
Kate L. Lapane, PhD, Brian J. Quilliam, PhD, Carmela Benson, MS, Wing Chow, PharmD, MPH, Myoung S. Kim, PhD, MBA
|
205—216
|
Christina A. Porucznik, PhD, MSPH, Erin M. Johnson, MPH, Robert T. Rolfs, MD, MPH, Brian C. Sauer, PhD
|
217—224
|
Case Studies
Nabil A. Khan, BA, Maria A. Sullivan, MD, PhD, Michael G. Vitale, MD, MPH, Mary Ellen Tresgallo, DNP, MPH, MS, John M. Saroyan, MD
|
225—230
|